AzTrials
AzTrials

Composite ResinsNCT07518537

Bulk-Fill Composite Restorations: Clinical Evaluation

A study testing Thermoviscous bulk-fill composite restoration, Sonic-activated bulk-fill composite restoration and Flowable bulk-fill composite restoration in people with Composite Resins and Dental Caries Class II, run by Ataturk University at 1 site in Turkey (Türkiye).

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This randomized controlled clinical study aims to evaluate the clinical performance of five different bulk-fill composite materials representing distinct technological approaches according to the World Dental Federation (FDI) criteria. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Composite Resins, Dental Caries Class II
What is being tested?
Thermoviscous bulk-fill composite restoration, Sonic-activated bulk-fill composite restoration and Flowable bulk-fill composite restoration
Could I receive a placebo?
No, everyone receives an active treatment
How many people
70 participants
Where
1 siteTurkey (Türkiye)
Study dates
20 May 2026to 20 Jul 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Patients aged 18 years and older
  • Patients in good general health (systemically healthy)
  • Patients with good oral hygiene
  • Patients with good periodontal health
  • Presence of at least one posterior tooth requiring restoration
  • Teeth must be vital and asymptomatic
Show all 11Show fewer
  • Teeth must have proximal contact with adjacent teeth on both mesial and distal surfaces
  • Teeth must be in functional occlusion with an antagonist tooth
  • Presence of at least one carious lesion not extending deeper than two-thirds of dentin, with a clinical ICDAS code ≤ 3
  • Absence of periapical pathology confirmed by radiographic evaluation
  • Patients who voluntarily agree to participate and provide written informed consent

Who cannot join

  • Presence of any systemic disease
  • Poor oral hygiene
  • Presence of active or severe periodontal disease
  • Teeth with previous restorations or endodontic treatment
  • Non-vital (devitalized) or symptomatic teeth
  • Patients who are pregnant or breastfeeding
Show all 10Show fewer
  • Patients undergoing active orthodontic treatment
  • Presence of parafunctional habits (e.g., bruxism) or xerostomia
  • Current tobacco use or history of heavy smoking
  • Patients unwilling or unable to attend follow-up visits

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Cemile Arslan, Research Assistant contact

+905396845019

cemilegonul15@gmail.com

Turkey (Türkiye)1 site
  • Atatürk University Faculty of Dentistry

    Erzurum, 25240

    Cemile Arslan, Research Asisistant, +905396845019, cemilegonul15@gmail.com

    Cemile Arslan, Research Assistant

Other trials in Turkey (Türkiye)

About this study

Official title: Clinical Evaluation of Restorations Performed With Bulk-Fill Composites of Different Technologies According to FDI Criteria: A Randomized Controlled Clinical Follow-Up Study

This randomized controlled clinical study aims to evaluate the clinical performance of five different bulk-fill composite materials representing distinct technological approaches according to the World Dental Federation (FDI) criteria. The materials include a thermoviscous bulk-fill composite applied with preheating, a sonic-activated bulk-fill composite, a flowable bulk-fill composite, an ORMOCER-based bulk-fill composite, and a conventional bulk-fill composite. Restorations will be clinically assessed at baseline, 1 month, 6 months, and 12 months for esthetic, functional, and biological outcomes.

Read the detailed description

This randomized controlled clinical follow-up study is planned to evaluate the clinical performance of posterior restorations performed with five different bulk-fill composite materials representing distinct technological approaches. The materials to be investigated include a thermoviscous bulk-fill composite applied with preheating, a sonic-activated bulk-fill composite, a flowable bulk-fill composite, an ORMOCER based bulk-fill composite, and a conventional bulk-fill composite.

The study will be conducted in patients requiring direct posterior restorations. After cavity preparation and restorative procedures performed according to the manufacturers' instructions, restorations will be placed using the assigned bulk-fill composite material. Clinical evaluations will be performed according to the World Dental Federation (FDI) criteria. The restorations will be assessed in terms of esthetic, functional, and biological properties.

Follow-up examinations will be carried out at baseline, 1 month, 6 months, and 12 months. The primary aim of the study is to compare the short-term clinical performance of bulk-fill composite materials with different technological characteristics. The findings are expected to provide clinically relevant information regarding the effectiveness and reliability of these restorative materials in posterior teeth.

Being tested
Thermoviscous bulk-fill composite restoration, Sonic-activated bulk-fill composite restoration, Flowable bulk-fill composite restoration, ORMOCER-based bulk-fill composite restoration, Conventional bulk-fill composite restoration
Keywords
FDI Criteria, Clinical Evaluation, Bulkfill, Composite Resins, Thermoviscous, Sonicfill, Clinical Trial

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Thermoviscous bulk-fill composite restorationOther

    Posterior restorations in this group will be performed using a thermoviscous bulk-fill composite material applied after preheating according to the manufacturer's instructions.

  • Sonic-activated bulk-fill composite restorationOther

    Posterior restorations in this group will be performed using a sonic-activated bulk-fill composite material with reduced viscosity during placement, according to the manufacturer's instructions.

  • Flowable bulk-fill composite restorationOther

    Posterior restorations in this group will be performed using a flowable bulk-fill composite material according to the manufacturer's instructions.

  • ORMOCER-based bulk-fill composite restorationOther

    Posterior restorations in this group will be performed using an ORMOCER-based bulk-fill composite material according to the manufacturer's instructions.

  • Conventional bulk-fill composite restorationOther

    Posterior restorations in this group will be performed using a conventional bulk-fill composite material according to the manufacturer's instructions.

Study groups in NCT07518537
Study groupRoleWhat they receive
ViscolorExperimentalParticipants assigned to this group will receive posterior restorations using a thermoviscous bulk-fill composite material applied after preheating according to the manufacturer's instructions.
Receives: Other: Thermoviscous bulk-fill composite restoration
SonicFillExperimentalParticipants assigned to this group will receive posterior restorations using a sonic-activated bulk-fill composite material with reduced viscosity during placement, according to the manufacturer's instructions.
Receives: Other: Sonic-activated bulk-fill composite restoration
Estelite Bulk FlowExperimentalParticipants assigned to this group will receive posterior restorations using a flowable bulk-fill composite material applied according to the manufacturer's instructions.
Receives: Other: Flowable bulk-fill composite restoration
Admira Fusion XtraExperimentalParticipants assigned to this group will receive posterior restorations using an ORMOCER-based bulk-fill composite material applied according to the manufacturer's instructions.
Receives: Other: ORMOCER-based bulk-fill composite restoration
Filltek Bulkfill CompositeExperimentalParticipants assigned to this group will receive posterior restorations using a conventional bulk-fill composite material applied according to the manufacturer's instructions.
Receives: Other: Conventional bulk-fill composite restoration

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Clinical performance according to FDI criteria

    The clinical performance of posterior restorations will be evaluated according to World Dental Federation (FDI) criteria, including esthetic, functional, and biological properties.

    Measured: Baseline (1 month), 6 months, and 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Apr 2026
  2. Study start20 May 2026 (estimated)
  3. Primary completion20 Jun 2027 (estimated)
  4. Study completion20 Jul 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
This study will use a randomized parallel-group design. Participants will be randomly assigned to one of the study groups, and all eligible posterior restorations within the same participant will be restored using the same assigned bulk-fill composite material. The number of restorations may vary among participants according to individual treatment needs.
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
70 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07518537
Sponsor's protocol ID
TDH-2026-17149
Other IDs
TDH-2026-17149
Status last verified
Apr 2026
First submitted
31 Mar 2026
Last updated
8 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Thermoviscous bulk-fill composite restoration, Sonic-activated bulk-fill composite restoration and Flowable bulk-fill composite restoration in people with Composite Resins and Dental Caries Class II, run by Ataturk University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 8 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Cemile Arslan, Research Assistant (+905396845019, cemilegonul15@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Clinical performance according to FDI criteria (time frame: Baseline (1 month), 6 months, and 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Apr 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in